文献速递烧伤创面修复

谷氨酰胺补充对烧伤患者的影响:系统综述与Meta分析

Glutamine Supplementation on Burn Patients: A Systematic Review and Meta-analysis.
PubMed 文献 · J Burn Care Res · 2024-01-01

该系统综述与Meta分析检索多个数据库至2023年10月,纳入22项随机试验共2170例烧伤患者,评估谷氨酰胺补充对住院时间、院内死亡、感染和创面愈合的影响。结果显示谷氨酰胺缩短住院时间、改善创面愈合率与愈合时间、减少创面感染,但未改善非创面感染、院内死亡和ICU住院时间;作者不推荐常规使用,需未来大规模随机试验。

要点

  • 谷氨酰胺补充缩短烧伤患者住院时间(WMD=-7.95,95%CI -10.53至-5.36,I²=67.9%,16项试验)。
  • 谷氨酰胺改善创面愈合率(WMD=9.15,95%CI 6.30至12.01,I²=82.7%,6项研究)和愈合时间(WMD=-5.84,95%CI -7.42至-4.27,I²=45.7%,7项研究)。
  • 谷氨酰胺减少创面感染(RR=0.38,95%CI 0.21至0.69,I²=0%,3项试验),但未改善非创面感染、院内死亡和ICU住院时间。

核心结论

  • 基于当前可用数据,作者不推荐烧伤患者常规使用谷氨酰胺补充。
  • 未来仍需大规模随机试验来得出谷氨酰胺对烧伤患者效果的结论。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Cochrane Central Register、EMBASE、Google scholar、Wanfang data和ClinicalTrials.gov至2023年10月。
  • 纳入22项随机试验,共随机2170例患者。

主要发现

  • 谷氨酰胺补充缩短住院时间(WMD=-7.95,95%CI -10.53至-5.36,I²=67.9%,16项试验)。
  • 谷氨酰胺改善创面愈合率(WMD=9.15,95%CI 6.30至12.01,I²=82.7%,6项研究)和创面愈合时间(WMD=-5.84,95%CI -7.42至-4.27,I²=45.7%,7项研究)。
  • 谷氨酰胺减少创面感染(RR=0.38,95%CI 0.21至0.69,I²=0%,3项试验),但未减少非创面感染(RR=0.88,95%CI 0.73至1.05,I²=39.6%,9项试验)。
  • 谷氨酰胺未改善院内死亡(RR=0.95,95%CI 0.74至1.22,I²=36.0%,8项试验)和ICU住院时间(WMD=1.85,95%CI -7.24至10.93,I²=78.2%,5项研究)。
  • 亚组分析显示阳性效应受小规模、单中心研究影响或基于此类研究。

临床怎么用

  • 作者不推荐烧伤患者常规使用谷氨酰胺补充。

局限性

  • 亚组分析显示阳性效应受小规模、单中心研究影响或基于此类研究。
  • 未来仍需大规模随机试验来得出谷氨酰胺对烧伤患者效果的结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

To evaluate the effect of glutamine supplement on patients with burns, we conducted a systematic review and meta-analysis via synthesizing up-to-date studies. Databases including PubMed, Cochrane Central Register, EMBASE, Google scholar, Wanfang data, and ClinicalTrials.gov were searched up to October 2023 to find randomized trials evaluating glutamine supplement on patients with burns. The main outcomes included hospital stay, in-hospital mortality, infection, and wound healing. Twenty-two trials that randomized a total of 2170 patients were included in this meta-analysis. Pooled the length of hospital stay was shortened by glutamine supplement (weighted mean differences [WMD] = -7.95, 95% confidence interval [CI] -10.53 to -5.36, I2 = 67.9%, 16 trials). Both pooled wound healing rates (WMD = 9.15, 95% CI 6.30 to 12.01, I2 = 82.7%, 6 studies) and wound healing times (WMD = -5.84, 95% CI -7.42 to -4.27, I2 = 45.7%, 7 studies) were improved by glutamine supplement. Moreover, glutamine supplement reduced wound infection (risk ratios [RR] = 0.38, 95% CI 0.21 to 0.69, I2 = 0%, 3 trials), but not nonwound infection (RR = 0.88, 95% CI 0.73 to 1.05, I2 = 39.6%, 9 trials). Neither in-hospital mortality (RR = 0.95, 95% CI 0.74 to 1.22, I2 = 36.0%, 8 trials) nor the length of intensive care unit stay (WMD = 1.85, 95% CI -7.24 to 10.93, I2 = 78.2%, 5 studies) was improved by glutamine supplement. Subgroup analysis showed positive effects were either influenced by or based on small-scale, single-center studies. Based on the current available data, we do not recommend the routine use of glutamine supplement for burn patients in hospital. Future large-scale randomized trials are still needed to give a conclusion about the effect of glutamine supplement on burn patients.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Tao W, Xu G, Zhou J, et al. Glutamine Supplementation on Burn Patients: A Systematic Review and Meta-analysis. J Burn Care Res. 2024. PMID: 38243579. doi:10.1093/jbcr/irae007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。